Pharmacological Treatment Of Depression In Late Life
Carl Salzman*, Lon S. Schneider, and George
Alexopoulos
REFERENCES
1. Abernethy DR, Greenblatt DJ, Shader RI. Imipramine and desipramine disposition in the elderly. J Pharmacol Exp Ther 1985;232:183-188.
2. Ackerman DL, Greenland S, Bystritsky, et al. Characteristics of fluoxetine versus placebo responders in a randomized trial of geriatric depression. Psychopharmacol Bull 1997;33:707-714.
3. Alexopoulos GS. The assessment and treatment of depressed-demented patients. In: Nelson JC, ed. Geriatric Psychopharmacology. New York, N.Y.: Marcel Dekker, Inc., 1998:223-243.
4. Alexopoulos GS, Salzman C. Treatment of depression with heterocyclic antidepressants, monoamine oxidase inhibitors, and psychomotor stimulants. In: Clinical Geriatric Psychopharmacology, Third Edition. Baltimore, MD: Williams and Wilkins, 1998:184-244.
5. Alexopoulos GS, Meyers BS, Young RC, et al. Clinically defined vascular depression. Am J Psychiatry 1997;154:562-565.
6. Alexopoulos G. Biological markers in geriatric depression. In: Schneider L, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc., 1994
7. Alexopoulos GS, Myers BS, Young RC, et al. The course of geriatric depression with "reversible dementia": A controlled study. Am J Psychiatry 1993;150:1693-1699.
8. Alexopoulos GS, Chester JG. Outcomes of geriatric depression. Clinics in geriatric medicine 1992;8:363‑76.
9. Alexopoulos GS, Young RC, Meyers BS, et al. Late-onset depression. Psychiatric Clinics of North America 1988;11:101-115.
10. Baldwin RC. Delusional and non-delusional depression in late life. Evidence for distinct subtypes. Br J of Psychiatry 1988;152:39-44.
11. Blazer DG. Epidemiology of late-life depression. In: Schneider LS, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994, pp 9-19.
12. Blazer D, Burchett B, Service C, et al. The association of age in depression among the elderly: an epidemiologic exploration. Journal of Gerontology 1991;46:M210-M215.
13. Branconnier RJ, Cole JO, Ghazvinian S, Spera KF, Oxenkrug GF, Bass JL. Clinical pharmacology of bupropion and imipramine in elderly depressives. J of Clin Psychiatry 1983;44(5, sec 2):130-133.
14. Caine E, Lyness JM, King DA, Connor L. Clinical and diagnostic heterogeneity in depression in late life. In: Schneider L, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994.
15. Conwell Y. Suicide in elderly patients. In: Schneider L, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994, pp 397-418.
16. Dawling S, Crome P, Heyer EJ. Nortriptyline therapy in elderly patients: Dosage prediction from plasma concentration at 24 hours after a single 50 mg dose. Brit J Psychiat 1981;139:413-416.
17. Dawling S. Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteers. Clin Pharmacokinetics 1980;5:394-401.
18. Devenand DP, Sano M, Tang M-X, et al. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 1996;53:175-182.
19. Dietch JT. The effect of nortriptyline in elderly patients with cardiac conduction disease. J of Clin Psychiatry 1990;51:65-67.
20. Furlanut M, and Benetello P. The pharmacokinetics of tricyclic antidepressant drugs in the elderly. Pharmacological Research 1990;22:15-25
21. Gottfries CG. Scandinavian experience with citalopram in the elderly. Int Clin Psychopharmacol 1996;41(suppl 1):41-44.
22. Hayes RL. ECG findings in geriatric depressives given trazodone, placebo or imipramine. J of Clin Psychiatry 1983;44:180-183.
23. Jarvik LF, Read SL, Mintz J, Neshkes RE. Pretreatment orthostatic hypotension in geriatric depression: predictor of response to imipramine and doxepin. J Clin Psychopharmacol 1983;3:368-72.
24. Kalayam B, Alexopoulos GS, Musiek FE, et al. Brainstorm evoked response abnormalities in late-life depression with vascular disease. Am J Psychiatry 1997;154:970-975.
25. Kane JM, Cole K, Sarantakos S, Howard A, Borenstein M. Safety and efficacy of bupropion in elderly patients: preliminary observations. J of Clin Psychiatry 1983;44(5, sec 2):134-136.
26. Katz IR, Parmelee PA, Streim JE. Depression in older patients in residential care. Am J Geriatric Psychiatry 1995;3:161-169.
27. Katz IR, Simpson GM, Curlik SM, Parmelee PA, Muhly C. Pharmacologic treatment of major depression for elderly patients in residential care settings. J Clin Psychiatry 990;51(suppl):41-47.
28. Katz IR, Simpson GM, Jethanandani V, et al. Steady state pharmacokinetics of nortriptyline in the frail elderly. Neuropsychopharmacology 1989;2:229-236.
29. Katz IR, Parmelee PA. Depression in the residential care elderly. In: Schneider L, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994.
30. Kim KY. Diagnosis and treatment of depression in the elderly. Int'l J Psychiatry in Medicine 1988;18:211-221.
31. Kitanaka I, Ross RJ, Cutler NR, et al. Altered hydroxydesipramine concentrations in elderly depressed patients. Clin Pharmacol Ther 1992;31:51-55.
32. Klawansky S. Meta-analysis on the pharmacotherapeutic treatment of depression in late life. In: Schneider L, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994.
33. Kocsis JH. Geriatric dysthymia. J Clin Psychiatry 1998;59 (suppl 10):13-15.
34. Krishnan KRR, Hays JC, and Blazer DG. MRI-defined vascular depression. Am J Psychiatry 1997;154:497-501.
35. Kumar A, Zhisong J, Bilker W, et al. Late-onset minor and major depression: early evidence for common neuroanatomical substrates detected by using MRI. Proc Natl Acad Scu USA 1998;95:7654-7658.
36. Kumar A, Schweizer E, Zhizong J, et al. Neuroanatomical substrates of late-life minor depression. Arch Neurol 1997;54:613-617.
37. Kumar V. Plasma levels and effects of nortriptyline in geriatric depressed patients. Acta Psychiatr Scand 1987;75:20-28.
38. Kutcher SP, Shulman KI, Reed K. Desipramine plasma concentration and therapeutic response in elderly depressives: a naturalistic pilot study. Can J of Psychiatry l986;31(8):752-4.
39. McCue RE. Plasma levels of nortriptyline and 10hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed. J of Psychiatry Res 1989;23:73-79.
40. McCue RE. 10-Hydroxynortriptyline and treatment effects in elderly depressed patients. J of Neuropsych & Clin Neurosciences 1989;1:176-180.
41. McCusker J, Cole M, Keller E, et al. Effectiveness of treatments of depression in older ambulatory patients. Arch Intern Med 1998;158:705-712.
42. Mittmann N, Hermann N, Einarson TR, et al. The efficacy, safety and tolerability of antidepressants in late life depression; a meta-analysis. J Affect Disord 1997;46:191-217.
43. Murphy E. The course and outcome of depression in late life. In: Schneider LS, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994.
44. Murphy E. The prognosis of depression in old age. Br J of Psychiatry l983;142:111-119.
45. Nelson JC. Treatment of major depression in the elderly. In: Nelson JC, ed. Geriatric Psychopharmacology. New York, N.Y.: Marcel Dekker, Inc., 1998:61-97.
46. Nelson JC, Atillasoy E, Mazure C, et al. Hydroxydesipramine in the elderly. J Clin Psychopharm 1988;8:428-433.
47. Nelson JC, Jatlow PI, Mazure C. Desipramine plasma levels and response in elderly melancholic patients. J of Clin Psychopharmacol l985;5(4):217-20.
48. Nies A, Robinson DS, Friedman MJ. Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry 1977;134:790-793.
49. Nobler MS, Devanand DP, Kim MK, et al. Fluoxetine treatment of dysthymia in the elderly. J Clin Psychiatry 1996;57:254-256.
50. Nyeth AL, Gottfries CG, Lyby K, at al. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without dementia. Acta Psychiatr Scand 1992;86:138-145.
51. Nyeth AL, Gottfries CG. The clinical efficacy of citalopram in the treatment of emotional disturbances in dementia patients. Br J Psychiatry 1990;157:894-901.
52. Parmelee PA, Katz IR, Lawton MP. Depression and mortality among institutionalized aged. J Gerontology: Psychological Sciences 1992;47:P3-10.
53. Pascualy M, Murburg MM, Veith RC. Cardiac risks of antidepressants in the elderly. In: Shamoian CA, ed. Psychopharmacological Treatment Complications in the Elderly. Washington: American Psychiatric Press, 1992.
54. Peabody CA, Whiteford HA, Hollister LE. Antidepressants and the elderly. J Am Geriatrics Society 1986;34:869-874.
55. Pfeiffer E, Baxter D, Candelora E, et al. Finding and treating depression in Alzheimer's patients: A study of the effects on patients and caregivers. Psychopharmacol Bull 1997;33:721-729.
56. Pickett P, Masand P, Murray GB. Psychostimulant treatment of geriatric depressive disorders secondary to medical illness. J Geriatric Psychiatry and Neurol 1990;3(3):146-151.
57. Plotkin DA, Gerson SG, Jarvik LF. Antidepressant drug treatment in the elderly. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York: Raven Press, l987;114911-58.
58. Pollock BG. Drug Interactions. In: Nelson JC, ed. Geriatric Psychopharmacology. New York, N.Y.: Marcel Dekker, Inc., 1998:43-60.
59. Pollock BG, Mulsant BH, Nebes R, et al. Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline. Am J Psychiatry 1998:155:1110-1112.
60. Rapp SR, Parisi SA, Walsh DA. Psychologicl dysfunction and physical health among elderly medical inpatients. J Consulting Clin Psychology 1988;56:851-855.
61. Reynolds CF, Schneider LS, Lebowitz BD, Kupfer DJ. Treatment of depression in the elderly: guidelines for primary care. In: Schneider LS, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994.
62. Reynolds CF. Treatment of depression in special populations. J Clin Psychiatry 1992a;53:9(suppl):45-53.
63. Reynolds CF, Frank E, Perel JM, et al. Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report. Amer J of Psychiatry 1992;149:1687-1692.
64. Reynolds CF, Perel JM, Frank E, et al. Open-Trial Maintenance Pharmacotherapy in Late-Life Depression: Survival Analysis. Psychiatry Res l989;27 225-31.
65. Rockwell E, Lam RW, Zisook S. Antidepressant drug studies in the elderly. Psychiatric Clin N America 1988;11:215-233.
66. Roose SP, and Suthers KM. Antidepressant response in late-life depression. J Clin Psychiatry 1998;59 (suppl 10):4-8.
67. Salzman C, (ed). Clinical Geriatric Psychopharmacology, Third Edition. Baltimore: Williams & Wilkins, 1998.
68. Salzman C. Monoamine oxidase inhibitors and atypical antidepressants. Clinics in Geriatric Medicine 1992;8:335-348.
69. Salzman C. Antidepressants. In: PF Lamy (ed). Clinics in Geriatric Medicine. Philadelphia, Saunders 1990:399-410.
70. Salzman C, Schneider L, Lebowitz B. Antidepressant treatment of very old patients. Am J Geriatric Psychiatry 1993;1:21-29.
71. Salzman C. Pharmacologic treatment of depression in the elderly. J Clin Psychiatry 1993;54(supp):23-28.
72. Salzman C. Pharmacological treatment of depression in the elderly. In: Schneider LS, Reynolds CF, Lebowitz BD, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, Inc. 1994.
73. Schneider LS, Small GW, Hamilton SH, et al. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Am J Geriatric Psychiatry 1997;5:97-106.
74. Schneider LS, Cooper TB, Severson JA. Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients. J Clin Psychopharmacol 1988;8:402-408.
75. Schneider LS, Sloane RB, Staples FR, Bender M. Pretreatment orthostatic hypotension as a predictor of response to nortriptyline in geriatric depression. J Clin Psychopharmacol l986;6(3);172-176.
76. Schneider LS, Cooper TB, Staples FR, et al. Prediction of individual dosage of nortriptyline in depressed elderly outpatients. J Clin Psychopharmacol 1987;7:311-314.
77. Schneider LS, Reynolds CF, Lebowitz B, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Proceedings of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, 1994.
78. Schneider LS. Comments on metaanalysis from a clinician's perspective. In: Schneider LS, Reynolds CF, Lebowitz B, Friedhoff A, eds. Diagnosis and Treatment of Depression in Late Life: Proceedings of the NIH Consensus Development Conference. Washington, D.C.: American Psychiatric Press, 1994.
79. Schneider LS. Decreased platelet-3H-imipramine binding in primary major depression compared with depression secondary to medical illness in elderly oupatients. J of Affective Disorders 1988;15:195-200.
80. Shamoian CA, ed. Psychopharmacological Treatment Complications in the Elderly. Washington, D.C.: American Psychiatric Press, 1992.
81. Small GW, Salzman C. Treatment of depression with new and atypical antidepressants. In: Clinical Geriatric Psychopharmacology, Third Edition. Baltimore, MD: Williams and Wilkins, 1998:245-261.
82. Snaith RP. Present use of the Hamilton Depression Rating Scale: observations on method of assessment in research of depressive disorders. Br J Psychiatry 1996;168:594-597.
83. Stack JA. Pretreatment systolic orthostatic blood pressure (PSOP) and treatment response in elderly depressed inpatients. J Clin Psychopharm 1988;8:116-120.
84. Thapa PB, Gideon P, Cost TW, et al. Antidepressants and the risk of falls among nursing home residents. N Engl J Med 1998;339:875-882.
85. Thayssen P. Cardiovascular effects of imipramine and nortriptyline in elderly patients. Psychopharmacology 1981;74:360-364.
86. Veith RC, Raskind MA. The neurobiology of aging: does it predispose to depression? Neurobiol Aging 1988;9:101-117
87. von Moltke L, Greenblatt DJ, Shader RI. Clinical pharmacokinetics of antidepressants in the elderly. Clin Pharmacokinet 1993;24:141-160.
88. Wiener P, Alexopoulos GS, Kakuma T, et al. The limits of history-taking in geriatric depression. Am J Geriatric Psychiatry 1997;5:116-125.
89. Wilkins JN.
Desipramine increased circulating growth hormone in elderly depressed
patients: a pilot study. Psychoneuroendocrin
1989;14:195-202.
Back to Chapter
published 2000